Hematopoiesis and the Kidney

[1]  J. Epstein,et al.  Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia. , 2010, Blood.

[2]  W. Kaelin,et al.  Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss , 2010, Science.

[3]  R. Wenger,et al.  Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. , 2010, American journal of physiology. Renal physiology.

[4]  E. Huizinga,et al.  Erythrocytosis associated with a novel missense mutation in the HIF2A gene , 2010, Haematologica.

[5]  N. Kosaka,et al.  Structural and biological properties of erythropoietin in Xenopus laevis. , 2010, Experimental hematology.

[6]  S. Bachmann,et al.  Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. , 2010, Kidney international.

[7]  B. Buchholz,et al.  Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model , 2009, Proceedings of the National Academy of Sciences.

[8]  D. Kleinfeld,et al.  The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. , 2009, The Journal of clinical investigation.

[9]  W. Kaelin,et al.  A Feedback Loop Involving the Phd3 Prolyl Hydroxylase Tunes the Mammalian Hypoxic Response In Vivo , 2009, Molecular and Cellular Biology.

[10]  B. Buchholz,et al.  HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. , 2009, The American journal of pathology.

[11]  M. Buset,et al.  Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients. , 2009, Scandinavian journal of haematology.

[12]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[13]  S. Master,et al.  Erythrocytosis-associated HIF-2α Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline* , 2009, Journal of Biological Chemistry.

[14]  D. Katschinski.  In vivo functions of the prolyl‐4‐hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues , 2009, Acta physiologica.

[15]  R. Paus,et al.  Erythropoietin and the skin: a role for epidermal oxygen sensing? , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  P. Carmeliet,et al.  Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease , 2009, Nature Reviews Drug Discovery.

[17]  F. Galateau-Sallé,et al.  PHD2 mutation and congenital erythrocytosis with paraganglioma. , 2008, The New England journal of medicine.

[18]  C. Noguchi,et al.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage , 2008, Expert Reviews in Molecular Medicine.

[19]  A. Cariou,et al.  Extra-hematopoietic effects of erythropoietin. , 2008, Cardiovascular & hematological disorders drug targets.

[20]  C. Bartram,et al.  Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF 2 , 2008 .

[21]  Cheng-Ying Chu,et al.  Erythropoietins from teleosts , 2008, Cellular and Molecular Life Sciences.

[22]  T. Cenci,et al.  A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis , 2008, Haematologica.

[23]  A. Green,et al.  Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis. , 2008, Blood.

[24]  Kai-Uwe Eckardt,et al.  Epidermal Sensing of Oxygen Is Essential for Systemic Hypoxic Response , 2008, Cell.

[25]  J. Pouysségur,et al.  PHDs overactivation during chronic hypoxia “desensitizes” HIFα and protects cells from necrosis , 2008, Proceedings of the National Academy of Sciences.

[26]  W. Kaelin,et al.  Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. , 2008, Blood.

[27]  K. Takeda,et al.  Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. , 2008, Blood.

[28]  M. McMullin,et al.  A gain-of-function mutation in the HIF2A gene in familial erythrocytosis. , 2008, The New England journal of medicine.

[29]  K. Kaushansky,et al.  YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation. , 2007, Blood.

[30]  W. Rathmell,et al.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. , 2007, The Journal of clinical investigation.

[31]  K. Kivirikko,et al.  An Endoplasmic Reticulum Transmembrane Prolyl 4-Hydroxylase Is Induced by Hypoxia and Acts on Hypoxia-inducible Factor α* , 2007, Journal of Biological Chemistry.

[32]  M. McMullin,et al.  A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. , 2007, Blood.

[33]  J. Tisdale,et al.  HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. , 2007, Blood.

[34]  K. Takeda,et al.  Essential Role for Prolyl Hydroxylase Domain Protein 2 in Oxygen Homeostasis of the Adult Vascular System , 2007, Circulation.

[35]  G. Camenisch,et al.  Regulated function of the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins. , 2007, Antioxidants & redox signaling.

[36]  E. Rankin,et al.  Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. , 2007, The Journal of clinical investigation.

[37]  R. Johnson,et al.  Acute postnatal ablation of Hif-2α results in anemia , 2007, Proceedings of the National Academy of Sciences.

[38]  J. Fandrey,et al.  Nitric Oxide Modulates Oxygen Sensing by Hypoxia-inducible Factor 1-dependent Induction of Prolyl Hydroxylase 2* , 2007, Journal of Biological Chemistry.

[39]  K. Takeda,et al.  Placental but Not Heart Defects Are Associated with Elevated Hypoxia-Inducible Factor α Levels in Mice Lacking Prolyl Hydroxylase Domain Protein 2 , 2006, Molecular and Cellular Biology.

[40]  Roland H Wenger,et al.  Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.

[41]  Savita Khanna,et al.  Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point. , 2006, Free radical biology & medicine.

[42]  M. McMullin,et al.  A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  S. Perrotta,et al.  Von Hippel-Lindau – dependent polycythemia is endemic on the island of Ischia : identification of a novel cluster , 2005 .

[44]  R. DePinho,et al.  Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Dalgard,et al.  Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1* , 2005, Journal of Biological Chemistry.

[46]  N. Oldham,et al.  Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. , 2005, Molecular bioSystems.

[47]  L. del Peso,et al.  Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. , 2005, The Biochemical journal.

[48]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[49]  K. Kivirikko,et al.  Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  H. Pagel,et al.  Is the renal production of erythropoietin controlled by the brain stem? , 2005, American journal of physiology. Endocrinology and metabolism.

[51]  G. Camenisch,et al.  Copper-dependent activation of hypoxia-inducible factor ( HIF ) – 1 : implications for ceruloplasmin regulation , 2005 .

[52]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[53]  W. Jelkmann,et al.  Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. , 2005, The Biochemical journal.

[54]  J. Richardson,et al.  HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner. , 2005, Blood.

[55]  K. Maiese,et al.  New avenues of exploration for erythropoietin. , 2005, JAMA.

[56]  Fatima Mechta-Grigoriou,et al.  JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress , 2004, Cell.

[57]  A. Harris,et al.  Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor* , 2004, Journal of Biological Chemistry.

[58]  K. Eckardt,et al.  Persistent induction of HIF‐1α and ‐2α in cardiomyocytes and stromal cells of ischemic myocardium , 2004 .

[59]  V. Erdmann,et al.  Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cells , 2004 .

[60]  W. Jelkmann,et al.  Beneficial and ominous aspects of the pleiotropic action of erythropoietin , 2004, Annals of Hematology.

[61]  P. Jaakkola,et al.  Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. , 2004, The Biochemical journal.

[62]  M. Wood,et al.  Regulation of HIF prolyl hydroxylases by hypoxia‐inducible factors , 2004, Journal of cellular biochemistry.

[63]  C. Dalgard,et al.  Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. , 2004, The Biochemical journal.

[64]  K. Kivirikko,et al.  Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases* , 2004, Journal of Biological Chemistry.

[65]  J. D. Engel,et al.  Hepatic Erythropoietin Gene Regulation by GATA-4* , 2004, Journal of Biological Chemistry.

[66]  L. del Peso,et al.  The von Hippel Lindau/Hypoxia-inducible Factor (HIF) Pathway Regulates the Transcription of the HIF-Proline Hydroxylase Genes in Response to Low Oxygen* , 2003, Journal of Biological Chemistry.

[67]  Christian Frelin,et al.  Hypoxia Up-regulates Prolyl Hydroxylase Activity , 2003, Journal of Biological Chemistry.

[68]  K. Kivirikko,et al.  Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor* , 2003, Journal of Biological Chemistry.

[69]  J. Pouysségur,et al.  HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.

[70]  B. Brüne,et al.  Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. , 2003, Molecular biology of the cell.

[71]  G. Semenza,et al.  Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia‐Reperfusion Injury , 2003, Circulation.

[72]  A. Harris,et al.  Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. , 2003, Cancer research.

[73]  B. Bowen,et al.  Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. , 2003, Biochemical and biophysical research communications.

[74]  W. Jelkmann,et al.  Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing , 2003, Journal of Cell Science.

[75]  Y. Fujii‐Kuriyama,et al.  HLF/HIF‐2α is a key factor in retinopathy of prematurity in association with erythropoietin , 2003, The EMBO journal.

[76]  J. Jelinek,et al.  Mutations in the VHL gene in sporadic apparently congenital polycythemia. , 2003, Blood.

[77]  David Mole,et al.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia , 2002, Nature Genetics.

[78]  Y. Dor,et al.  Activated pp60c-Src Leads to Elevated Hypoxia-inducible Factor (HIF)-1α Expression under Normoxia* , 2002, The Journal of Biological Chemistry.

[79]  L. Rimsza,et al.  Developmental changes in the expression of transcription factors GATA‐1, ‐2 and ‐3 during the onset of human medullary haematopoiesis , 2002, British journal of haematology.

[80]  Jianhe Huang,et al.  Sequence Determinants in Hypoxia-inducible Factor-1α for Hydroxylation by the Prolyl Hydroxylases PHD1, PHD2, and PHD3* , 2002, The Journal of Biological Chemistry.

[81]  Mircea Ivan,et al.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Cheung,et al.  Erythropoietin Modulates Calcium Influx through TRPC2* , 2002, The Journal of Biological Chemistry.

[83]  Matthias Schramm,et al.  Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. , 2002, Biochemical and biophysical research communications.

[84]  T. Iwanaga,et al.  Epididymis is a novel site of erythropoietin production in mouse reproductive organs. , 2002, Biochemical and biophysical research communications.

[85]  G. Semenza,et al.  Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway* , 2002, The Journal of Biological Chemistry.

[86]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  Christopher J Schofield,et al.  Hypoxia-inducible Factor (HIF) Asparagine Hydroxylase Is Identical to Factor Inhibiting HIF (FIH) and Is Related to the Cupin Structural Family* , 2002, The Journal of Biological Chemistry.

[88]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[89]  Till Acker,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[90]  M. Seyfarth,et al.  Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. , 2002, Blood.

[91]  N. Sang,et al.  Carboxyl-Terminal Transactivation Activity of Hypoxia-Inducible Factor 1α Is Governed by a von Hippel-Lindau Protein-Independent, Hydroxylation-Regulated Association with p300/CBP , 2002, Molecular and Cellular Biology.

[92]  N. Yaegashi,et al.  Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle. , 2002, Molecular human reproduction.

[93]  Kai-Uwe Eckardt,et al.  Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. , 2002, Journal of the American Society of Nephrology : JASN.

[94]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[95]  K. Polyak,et al.  Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression) , 2002, Oncogene.

[96]  K. Flanders,et al.  Erythropoietin receptor signalling is required for normal brain development. , 2002, Development.

[97]  M. Gassmann,et al.  Dissecting hypoxia‐dependent and hypoxia‐independent steps in the HIF‐1α activation cascade: implications for HIF‐1α gene therapy , 2001 .

[98]  R. Brace,et al.  Expression of erythropoietin mRNA, protein and receptor in ovine fetal membranes. , 2001, Placenta.

[99]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[100]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[101]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[102]  P. Ratcliffe,et al.  Independent function of two destruction domains in hypoxia‐inducible factor‐α chains activated by prolyl hydroxylation , 2001, The EMBO journal.

[103]  S. Juul,et al.  Erythropoietin acts as a trophic factor in neonatal rat intestine , 2001, Gut.

[104]  J. Ihle,et al.  The distal region and receptor tyrosines of the Epo receptor are non‐essential for in vivo erythropoiesis , 2001, The EMBO journal.

[105]  G. Semenza,et al.  HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.

[106]  M. Gassmann,et al.  Induction of HIF–1α in response to hypoxia is instantaneous , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[107]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[108]  H. Sucov,et al.  A developmental transition in definitive erythropoiesis: erythropoietin expression is sequentially regulated by retinoic acid receptors and HNF4. , 2001, Genes & development.

[109]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[110]  J. Fandrey,et al.  Erythropoietin gene expression in different areas of the developing human central nervous system. , 2000, Brain research. Developmental brain research.

[111]  S. Masuda,et al.  Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. , 2000, American journal of physiology. Endocrinology and metabolism.

[112]  M. Gassmann,et al.  Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. , 2000, Biochimica et biophysica acta.

[113]  Eamonn R. Maher,et al.  Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein* , 2000, The Journal of Biological Chemistry.

[114]  M. Gassmann,et al.  Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation , 2000 .

[115]  J. Peng,et al.  The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[116]  E. Goldwasser,et al.  A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene , 2000 .

[117]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[118]  S. Masuda,et al.  The oviduct produces erythropoietin in an estrogen- and oxygen-dependent manner. , 2000, American journal of physiology. Endocrinology and metabolism.

[119]  G. Semenza,et al.  Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[120]  G. Semenza.  HIF-1: mediator of physiological and pathophysiological responses to hypoxia. , 2000, Journal of applied physiology.

[121]  A. Koong,et al.  Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.

[122]  P. W. Conrad,et al.  EPAS1 trans-Activation during Hypoxia Requires p42/p44 MAPK* , 1999, The Journal of Biological Chemistry.

[123]  J. Pouysségur,et al.  p42/p44 Mitogen-activated Protein Kinases Phosphorylate Hypoxia-inducible Factor 1α (HIF-1α) and Enhance the Transcriptional Activity of HIF-1* , 1999, The Journal of Biological Chemistry.

[124]  M. Iruela-Arispe,et al.  Inactivation of erythropoietin leads to defects in cardiac morphogenesis. , 1999, Development.

[125]  E. Mackenzie,et al.  A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[126]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[127]  G. Semenza,et al.  Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. , 1999, Developmental biology.

[128]  Y. Fujii‐Kuriyama,et al.  Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300 , 1999, The EMBO journal.

[129]  Yuichi Makino,et al.  Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway* , 1999, The Journal of Biological Chemistry.

[130]  T. Beaty,et al.  Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. , 1999, The Journal of clinical investigation.

[131]  P. Ratcliffe,et al.  Oxygen-regulated and Transactivating Domains in Endothelial PAS Protein 1: Comparison with Hypoxia-inducible Factor-1α* , 1999, The Journal of Biological Chemistry.

[132]  L. Poellinger,et al.  Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of theCBP/p300 coactivator by the hypoxia‐induciblefactor‐1α , 1998, The EMBO journal.

[133]  J. Fandrey,et al.  Erythropoietin mRNA Expression in Human Fetal and Neonatal Tissue , 1998 .

[134]  R. Hammer,et al.  The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. , 1998, Genes & development.

[135]  T. Harvey,et al.  NMR structure of human erythropoietin and a comparison with its receptor bound conformation , 1998, Nature Structural Biology.

[136]  S. Masuda,et al.  Estrogen-dependent Production of Erythropoietin in Uterus and Its Implication in Uterine Angiogenesis* , 1998, The Journal of Biological Chemistry.

[137]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[138]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[139]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[140]  N. Miyasaka,et al.  Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. , 1998, Blood.

[141]  A. Yoshimura,et al.  Identification of a cytoplasmic motif in the erythropoietin receptor required for receptor internalization , 1998, FEBS letters.

[142]  J. Marine,et al.  Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors , 1998, Cell.

[143]  A. Cumano,et al.  Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis , 1998, Cell.

[144]  E. Morishita,et al.  In vivo evidence that erythropoietin protects neurons from ischemic damage. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[145]  K. Kivirikko,et al.  Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[146]  M. Gassmann,et al.  Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. , 1998, Genes & development.

[147]  E. Wintour,et al.  Developmental regulation of erythropoietin and erythropoiesis. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[148]  J. Caro,et al.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. , 1997, The Journal of biological chemistry.

[149]  K. Eckardt,et al.  Evidence against a major role of adenosine in oxygen-dependent regulation of erythropoietin in rats. , 1997, Kidney international.

[150]  G. Semenza,et al.  Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α , 1997, The Journal of Biological Chemistry.

[151]  M. Bondurant,et al.  The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. , 1997, Blood.

[152]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[153]  H. Miyazaki,et al.  Effects and serum levels of thrombopoietin in a case of chronic thrombocytopenia with achondroplasia. , 1997, International journal of hematology.

[154]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[155]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[156]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[157]  T. Senn,et al.  Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. , 1997, Blood.

[158]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[159]  Y Fujii-Kuriyama,et al.  A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[160]  Y. Miyakawa,et al.  Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[161]  H. Handa,et al.  Characterization of the Human Thrombopoietin Gene Promoter , 1997, The Journal of Biological Chemistry.

[162]  M. Nagao,et al.  Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit* , 1997, The Journal of Biological Chemistry.

[163]  R. Salgia,et al.  Thrombopoietin induces activation of the phosphatidylinositol‐3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL , 1997, Journal of cellular physiology.

[164]  W. Risau,et al.  HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1α and developmentally expressed in blood vessels , 1997, Mechanisms of Development.

[165]  S. Klinken,et al.  Lyn tyrosine kinase is essential for erythropoietin‐induced differentiation of J2E erythroid cells , 1997, The EMBO journal.

[166]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[167]  J. Hogenesch,et al.  Characterization of a Subset of the Basic-Helix-Loop-Helix-PAS Superfamily That Interacts with Components of the Dioxin Signaling Pathway* , 1997, The Journal of Biological Chemistry.

[168]  V. Broudy,et al.  Human platelets display high-affinity receptors for thrombopoietin. , 1997, Blood.

[169]  W. Zhou,et al.  Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment. , 1997, Blood.

[170]  T. Hirano,et al.  An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT , 1997, Oncogene.

[171]  Y. Miura,et al.  Negative regulation of the erythropoietin gene expression by the GATA transcription factors. , 1997, Blood.

[172]  M. Gassmann,et al.  The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. , 1997, Kidney international.

[173]  J. Iredale,et al.  Sites of erythropoietin production. , 1997, Kidney international.

[174]  D W Lübbers,et al.  Heterogeneities and profiles of oxygen pressure in brain and kidney as examples of the pO2 distribution in the living tissue. , 1997, Kidney international.

[175]  B. Ebert,et al.  Oxygen regulated gene expression: erythropoietin as a model system. , 1997, Kidney international.

[176]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[177]  N. Miyasaka,et al.  Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. , 1996, Blood.

[178]  D. Livingston,et al.  Activation of Hypoxia-inducible Transcription Factor Depends Primarily upon Redox-sensitive Stabilization of Its α Subunit* , 1996, The Journal of Biological Chemistry.

[179]  E. Morishita,et al.  Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death , 1996, Neuroscience.

[180]  E. Gordon-Smith,et al.  Serum thrombopoietin levels in patients with aplastic anaemia , 1996, British journal of haematology.

[181]  A. D’Andrea,et al.  Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2. , 1996, Blood.

[182]  S. Patel,et al.  Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. , 1996, Biochemistry.

[183]  S. Bhattacharya,et al.  An essential role for p300/CBP in the cellular response to hypoxia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[184]  M. Hokom,et al.  The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis , 1996, British journal of haematology.

[185]  S. Jacobsen,et al.  Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro. , 1996, Blood.

[186]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[187]  W. Vainchenker,et al.  Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. , 1996, Blood.

[188]  R. Klausner,et al.  Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[189]  S. Koury,et al.  Erythropoietin production by interstitial cells of hypoxic monkey kidneys , 1996, British journal of haematology.

[190]  H. Beug,et al.  Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[191]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[192]  H. Makino,et al.  Glomerular expression of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in patients with various forms of glomerulonephritis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[193]  Lesley J. Murray,et al.  Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin− primitive progenitor cells , 1996 .

[194]  N. Mahmud,et al.  Activity of the ligand for c‐mpl, thrombopoietin, in early haemopoiesis , 1996, British journal of haematology.

[195]  H. Broxmeyer,et al.  Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. , 1996, Blood.

[196]  F. Ishida,et al.  Regulation of Serum Thrombopoietin Levels by Platelets and Megakaryocytes in Patients with Aplastic Anaemia and Idiopathic Thrombocytopenic Purpura , 1996, Thrombosis and Haemostasis.

[197]  E. Morishita,et al.  Anti-erythropoietin receptor monoclonal antibody: epitope mapping, quantification of the soluble receptor, and detection of the solubilized transmembrane receptor and the receptor-expressing cells. , 1996, Blood.

[198]  A. Maxwell,et al.  LOCALIZATION OF ERYTHROPOIETIN GENE EXPRESSION IN PROXIMAL RENAL TUBULAR CELLS DETECTED BY DIGOXIGENIN‐LABELLED OLIGONUCLEOTIDE PROBES , 1996, The Journal of pathology.

[199]  T. Tsuruo,et al.  Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. , 1996, European journal of biochemistry.

[200]  O. Hankinson,et al.  The Role of the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) in Hypoxic Induction of Gene Expression , 1996, The Journal of Biological Chemistry.

[201]  A. Matsumoto,et al.  A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders , 1996, British journal of haematology.

[202]  H. Suliman,et al.  Cloning of a cDNA encoding bovine erythropoietin and analysis of its transcription in selected tissues. , 1996, Gene.

[203]  P Roth,et al.  Colony stimulating factor‐1 expression is developmentally regulated in the mouse , 1996, Journal of leukocyte biology.

[204]  N. Young,et al.  Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. , 1996, Blood.

[205]  A. Ritchie,et al.  Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor‐Dependent Cell Line, M07e , 1996, Stem cells.

[206]  K. Conrad,et al.  Expression of erythropoietin by the human placenta , 1996 .

[207]  B. Groner,et al.  Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. , 1996, The EMBO journal.

[208]  A. Kurtz,et al.  Divergent regulation of vascular endothelial growth factor and of erythropoietin gene expression in vivo , 1996, Pflügers Archiv.

[209]  M. Gassmann,et al.  Erythropoietin Gene Expression in Human, Monkey and Murine Brain , 1996, The European journal of neuroscience.

[210]  M. Brizzi,et al.  Effects of recombinant human megakaryocyte growth and development factor on platelet activation. , 1996, Blood.

[211]  S. Busfield,et al.  Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[212]  A. Gurney,et al.  Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. , 1996, Blood.

[213]  T. Nagasawa,et al.  Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. , 1996, Blood.

[214]  E. Friedman,et al.  The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. , 1996, The New England journal of medicine.

[215]  F. D. de Sauvage,et al.  Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.

[216]  V. Broudy,et al.  Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. , 1996, Experimental hematology.

[217]  I. Cavill,et al.  How to diagnose and correct iron deficiency during r-huEPO therapy--a consensus report. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[218]  V. D’Agati,et al.  Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. , 1996, Genes & development.

[219]  B. Druker,et al.  Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. , 1996, Blood.

[220]  R. Skoda,et al.  Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. , 1996, Blood.

[221]  K. Todokoro,et al.  Thrombopoietin induces activation of at least two distinct signaling pathways , 1995, FEBS letters.

[222]  P. Halloran,et al.  Acute Renal Injury In The Interferon-γ Gene Knockout Mouse: Effect On Cytokine Gene Expression1 , 1995 .

[223]  N. Komatsu,et al.  Thrombopoietin induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in a human thrombopoietin-dependent cell line. , 1995, Biochemical and biophysical research communications.

[224]  J. Chen,et al.  Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. , 1995, Blood.

[225]  T. Kato,et al.  Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. , 1995, Experimental hematology.

[226]  N. Fox,et al.  Murine thrombopoietin mRNA levels are modulated by platelet count. , 1995, Blood.

[227]  W. Parks,et al.  In situ hybridization of human erythropoietin in pre- and postnatal kidneys. , 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

[228]  J. Krosl,et al.  Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin‐induced cell proliferation and Stat5 activation. , 1995, The EMBO journal.

[229]  M. Okuma,et al.  Thrombopoietin, c‐Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists‐induced aggregation in platelets in vitro , 1995, FEBS letters.

[230]  J. Ihle.  Cytokine receptor signalling , 1995, Nature.

[231]  G. Krystal,et al.  Phosphorylation of Tyrosine 503 in the Erythropoietin Receptor (EpR) Is Essential for Binding the P85 Subunit of Phosphatidylinositol (PI) 3-Kinase and for EpR-associated PI 3-Kinase Activity (*) , 1995, The Journal of Biological Chemistry.

[232]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[233]  E. Stanley,et al.  Colony‐stimulating factor‐1 expression in the human fetus and newborn , 1995, Journal of leukocyte biology.

[234]  H. Miyazaki,et al.  Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors , 1995 .

[235]  H. Lodish,et al.  Interaction of the erythropoietin and stem-cell-factor receptors , 1995, Nature.

[236]  V. Broudy,et al.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. , 1995, The Journal of clinical investigation.

[237]  M. Remberger,et al.  Cytokines in fetal blood and amniotic fluid in Rh‐immunized pregnancies , 1995, Obstetrics and gynecology.

[238]  H. Lu,et al.  Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. , 1995, Blood.

[239]  F. Bazer,et al.  Colony-stimulating factor-1 in conceptus and uterine tissues in pigs. , 1995, Biology of reproduction.

[240]  T. Boone,et al.  Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. , 1995, Blood.

[241]  J. Johnston,et al.  Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. , 1995, Blood.

[242]  A. Gurney,et al.  Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[243]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[244]  D. Levy,et al.  Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.

[245]  R. Rosenberg,et al.  The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. , 1995, Blood.

[246]  S. Wickramasinghe,et al.  Expression of an erythropoietin‐like gene in the trout , 1995, British journal of haematology.

[247]  M. Gassmann,et al.  Localization of specific erythropoietin binding sites in defined areas of the mouse brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[248]  V. Broudy,et al.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[249]  T. Ogura,et al.  The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1 , 1995, Molecular and cellular biology.

[250]  V. Broudy,et al.  Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. , 1995, Blood.

[251]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[252]  J. Griffin,et al.  The c-Mpl Ligand (Thrombopoietin) Stimulates Tyrosine Phosphorylation of Jak2, Shc, and c-Mpl (*) , 1995, The Journal of Biological Chemistry.

[253]  A. Gurney,et al.  Genomic Structure , Chromosomal Localization , and Conserved Alternative Splice Forms of Thrombopoietin , 2002 .

[254]  W. Jelkmann,et al.  Role of protein kinase C in hepatic erythropoietin synthesis. , 1995, Experimental hematology.

[255]  E. Wintour,et al.  Erythropoietin gene expression in fetal and adult sheep kidney , 1995, British journal of haematology.

[256]  G. Semenza,et al.  Purification and Characterization of Hypoxia-inducible Factor 1 (*) , 1995, The Journal of Biological Chemistry.

[257]  J. Shutter,et al.  Cloning and Characterization of the Human Megakaryocyte Growth and Development Factor (MGDF) Gene (*) , 1995, The Journal of Biological Chemistry.

[258]  F. Grant,et al.  Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[259]  M. Rudnick,et al.  Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[260]  N. Seki,et al.  Molecular cloning and chromosomal localization of the human thrombopoietin gene , 1994, FEBS letters.

[261]  G. Semenza,et al.  Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. , 1994, The Journal of biological chemistry.

[262]  P. Ratcliffe,et al.  Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells. , 1994, Blood.

[263]  A. Gurney,et al.  Thrombocytopenia in c-mpl-deficient mice. , 1994, Science.

[264]  K. Yamagishi,et al.  A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. , 1994, The Journal of biological chemistry.

[265]  B. Ebert,et al.  Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[266]  J. Loffing,et al.  Distribution of ecto-5′-nucleotidase in the rat liver: effect of anaemia , 1994, Histochemistry.

[267]  M. C. Hu,et al.  Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI , 1994, Cell.

[268]  V. Broudy,et al.  Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin , 1994, Nature.

[269]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[270]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[271]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[272]  H. Lodish,et al.  Activation and inhibition of erythropoietin receptor function: role of receptor dimerization , 1994, Molecular and cellular biology.

[273]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[274]  R. Martino,et al.  Postrenal transplant erythrocytosis: Further evidence implicating erythropoietin production by the native kidneys , 1994, Annals of Hematology.

[275]  J. Spivak,et al.  Serum immunoreactive erythropoietin during the perioperative period. , 1994, Surgery.

[276]  H. Sato,et al.  Levels of serum colony-stimulating factors (CSFs) in patients on long-term haemodialysis. , 1994, Cytokine.

[277]  W. Jelkmann,et al.  Thyroid hormones enhance hypoxia-induced erythropoietin production in vitro. , 1994, Experimental hematology.

[278]  G. Semenza,et al.  Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. , 1993, Blood.

[279]  G. Remuzzi,et al.  Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[280]  P. Ratcliffe,et al.  Identification of the renal erythropoietin-producing cells using transgenic mice. , 1993, Kidney international.

[281]  G. Krystal,et al.  Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. , 1993, Blood.

[282]  J. Guénet,et al.  Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. , 1993, Oncogene.

[283]  J. Cook,et al.  Serum form of the erythropoietin receptor identified by a sequence- specific peptide antibody [see comments] , 1993 .

[284]  Franklin,et al.  Erythropoietin structure-function relationships: high degree of sequence homology among mammals. , 1993, Blood.

[285]  W. Vainchenker,et al.  Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. , 1993, Blood.

[286]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[287]  W. Hankins,et al.  The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[288]  P. Leder,et al.  Murine c‐mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. , 1993, The EMBO journal.

[289]  P. Ratcliffe,et al.  Oxygen-dependent expression of the erythropoietin gene in rat hepatocytes in vitro , 1993, Pflügers Archiv.

[290]  A. de la Chapelle,et al.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[291]  S. Masuda,et al.  Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: conversion from two classes of binding sites to a single class. , 1993, Blood.

[292]  H. Lodish,et al.  Structure, function, and activation of the erythropoietin receptor. , 1993, Blood.

[293]  P. Ratcliffe,et al.  Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. , 1993, Kidney international.

[294]  M. Goldberg,et al.  Modulators of protein kinase C inhibit hypoxia-induced erythropoietin production. , 1993, Experimental hematology.

[295]  M. Le Hir,et al.  Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[296]  D. Rao,et al.  Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. , 1993, New England Journal of Medicine.

[297]  D. Galson,et al.  Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements , 1992, Molecular and cellular biology.

[298]  G. Semenza,et al.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation , 1992, Molecular and cellular biology.

[299]  P. Ratcliffe,et al.  Renal innervation plays no role in oxygen-dependent control of erythropoietin mRNA levels. , 1992, The American journal of physiology.

[300]  P. Ratcliffe,et al.  Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. , 1992, The American journal of physiology.

[301]  J. Adamson,et al.  A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. , 1992, Kidney international.

[302]  S. Koury,et al.  Cellular sites of extrarenal and renal erythropoietin production in anaemic rats , 1992, British journal of haematology.

[303]  M. Goldberg,et al.  EFFECT OF INFLAMMATORY CYTOKINES ON HYPOXIA-INDUCED ERYTHROPOIETIN PRODUCTION , 1992 .

[304]  P. Ratcliffe,et al.  Age-dependent expression of the erythropoietin gene in rat liver and kidneys. , 1992, The Journal of clinical investigation.

[305]  P. Ratcliffe,et al.  Effect of inhibitors of oxidative phosphorylation on erythropoietin mRNA in isolated perfused rat kidneys. , 1991, The American journal of physiology.

[306]  R. W. Jones,et al.  Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[307]  S. Antonarakis,et al.  Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[308]  M. Goldberg,et al.  Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. , 1991, The Journal of biological chemistry.

[309]  S. Koury,et al.  Structure-function correlations in erythropoietin formation and oxygen sensing in the kidney , 1991, Klinische Wochenschrift.

[310]  K. Eckardt,et al.  Serial immunoreactive erythropoietin levels in autologous blood donors , 1991, Transfusion.

[311]  R. Weinmann,et al.  Enhancer element at the 3'-flanking region controls transcriptional response to hypoxia in the human erythropoietin gene. , 1991, The Journal of biological chemistry.

[312]  P. Ratcliffe,et al.  Organ distribution of erythropoietin messenger RNA in normal and uremic rats. , 1991, Kidney international.

[313]  S. Antonarakis,et al.  Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[314]  Mark J. Koury,et al.  Localization of cells producing erythropoietin in murine liver by in situ hybridization , 1991 .

[315]  W. Jelkmann,et al.  Isolated serum-free perfused rat kidneys release immunoreactive erythropoietin in response to hypoxia. , 1991, Endocrinology.

[316]  H. Scholz,et al.  Oxygen-dependent erythropoietin production by the isolated perfused rat kidney , 1991, Pflügers Archiv.

[317]  L. Zon,et al.  The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains , 1991, Molecular and cellular biology.

[318]  J. Spivak,et al.  Erythropoietin is both a mitogen and a survival factor. , 1991, Blood.

[319]  M. Goldberg,et al.  Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. , 1991, Blood.

[320]  F. Wendling,et al.  A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors , 1990, Cell.

[321]  H. Lodish,et al.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.

[322]  H. Baumgaertl,et al.  Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. , 1990, The American journal of physiology.

[323]  D. Klassen,et al.  Hepatitis-related hepatic erythropoietin production. , 1990, The American journal of medicine.

[324]  A. Kurtz,et al.  Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients. , 1990, Transplantation.

[325]  K. Eckardt,et al.  Role of excretory graft function for erythropoietin formation after renal transplantation , 1990 .

[326]  R. Mactier,et al.  Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis. , 1990, BMJ.

[327]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[328]  E. Goldwasser,et al.  Evidence suggesting negative regulation of the erythropoietin gene by ribonucleoprotein. , 1990, The Journal of biological chemistry.

[329]  R. Hakim,et al.  Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[330]  A. Anagnostou,et al.  Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[331]  R. W. Jones,et al.  Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection , 1990, The Journal of experimental medicine.

[332]  T. McDonald,et al.  Thrombopoietin derived from human embryonic kidney cells stimulates an increase in DNA content of murine megakaryocytes in vivo. , 1990, Experimental hematology.

[333]  G. Bakris,et al.  Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. , 1990, The New England journal of medicine.

[334]  C. March,et al.  A new cytokine receptor superfamily. , 1990, Trends in biochemical sciences.

[335]  A. D’Andrea,et al.  Human erythropoietin receptor: cloning, expression, and biologic characterization. , 1990, Blood.

[336]  L. Deaven,et al.  The gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19p. , 1990, Blood.

[337]  S. Piantadosi,et al.  Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.

[338]  H. Gisslinger,et al.  Erythropoietin treatment of anemia associated with multiple myeloma. , 1990, The New England journal of medicine.

[339]  K. Eckardt,et al.  Decline of erythropoietin formation at continuous hypoxia is not due to feedback inhibition. , 1990, The American journal of physiology.

[340]  M. Koury,et al.  Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. , 1990, Science.

[341]  K. Eckardt,et al.  Triggering of erythropoietin production by hypoxia is inhibited by respiratory and metabolic acidosis. , 1990, The American journal of physiology.

[342]  S. Antonarakis,et al.  Human erythropoietin gene expression in transgenic mice: multiple transcription initiation sites and cis-acting regulatory elements , 1990, Molecular and cellular biology.

[343]  N. Casadevall,et al.  Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. , 1990, Blood.

[344]  J. Adamson,et al.  Management of the anaemia of chronic renal failure with recombinant erythropoietin. , 1989, The Quarterly journal of medicine.

[345]  L. Solomon,et al.  Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis. , 1989, Kidney international.

[346]  B. Kaissling,et al.  Distribution of 5′-nucleotidase in the renal interstitium of the rat , 1989, Cell and Tissue Research.

[347]  H. Kozutsumi,et al.  Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[348]  H. Scholz,et al.  Erythropoietin in polycystic kidneys. , 1989, The Journal of clinical investigation.

[349]  T. Hirano,et al.  Interleukin-6 is a potent thrombopoietic factor in vivo in mice. , 1989, Blood.

[350]  M. Koury,et al.  Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration , 1989 .

[351]  J. Adamson,et al.  Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.

[352]  H. Ward,et al.  Serum erythropoietin levels after renal transplantation. , 1989, The New England journal of medicine.

[353]  M. Le Hir,et al.  Anemia induces 5'-nucleotidase in fibroblasts of cortical labyrinth of rat kidney. , 1989, Renal physiology and biochemistry.

[354]  K. Sawada,et al.  Receptors for erythropoietin in mouse and human erythroid cells and placenta. , 1989, Blood.

[355]  T. Quinn,et al.  Serum immunoreactive erythropoietin in HIV-infected patients. , 1989, JAMA.

[356]  T. Pincus,et al.  Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. , 1989, Arthritis and rheumatism.

[357]  S. Koury,et al.  Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. , 1989, The Journal of clinical investigation.

[358]  K. Eckardt,et al.  Regulation of erythropoietin production is related to proximal tubular function. , 1989, The American journal of physiology.

[359]  H. Lodish,et al.  Expression cloning of the murine erythropoietin receptor , 1989, Cell.

[360]  U Boutellier,et al.  Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia. , 1989, Journal of applied physiology.

[361]  S. Antonarakis,et al.  Polycythemia in transgenic mice expressing the human erythropoietin gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[362]  J. Royston,et al.  Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics. , 1989, The Quarterly journal of medicine.

[363]  L. Shultz,et al.  Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). , 1989, Experimental hematology.

[364]  M. Goldberg,et al.  Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. , 1988, Science.

[365]  M. Chandra,et al.  Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. , 1988, The Journal of pediatrics.

[366]  A. Dell,et al.  Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry. , 1988, Biochemistry.

[367]  W. Jelkmann,et al.  A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin , 1988, Pflügers Archiv.

[368]  K. Eckardt,et al.  Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[369]  M. Berridge,et al.  Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. , 1988, Blood.

[370]  F. Marumo,et al.  Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in Japan , 1988, The International journal of artificial organs.

[371]  L. Mailloux,et al.  Serum erythropoietin levels and hematocrit in end-stage renal disease: influence of the mode of dialysis. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[372]  R. Meagher,et al.  Modulation of erythropoietin production by adenosine. , 1988, The Journal of laboratory and clinical medicine.

[373]  P. Thompson.  CORONARY THROMBOLYSIS AND MYOCARDIAL SALVAGE BY TISSUE PLASMINOGEN ACTIVATOR , 1988, The Lancet.

[374]  R. Sasaki,et al.  Comparative structural study of N-linked oligosaccharides of urinary and recombinant erythropoietins. , 1988, Biochemistry.

[375]  M. Koury,et al.  Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by the placenta. , 1988, The Journal of clinical investigation.

[376]  J. Fisher,et al.  Pharmacokinetics of erythropoietin in intact and anephric dogs. , 1988, The Journal of laboratory and clinical medicine.

[377]  P. Altmann,et al.  ALUMINIUM CHELATION THERAPY IN DIALYSIS PATIENTS: EVIDENCE FOR INHIBITION OF HAEMOGLOBIN SYNTHESIS BY LOW LEVELS OF ALUMINIUM , 1988, The Lancet.

[378]  J. Adamson,et al.  The anemia of end-stage renal disease: hematopoietic progenitor cell response. , 1988, Kidney international.

[379]  H. Miyazaki,et al.  Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. , 1988, The Journal of biological chemistry.

[380]  F. Wendling,et al.  Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. , 1988, The Journal of clinical investigation.

[381]  M. Koury,et al.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. , 1988, Blood.

[382]  Y. Kim,et al.  Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin. Identification of des-arginine 166 erythropoietin. , 1987, The Journal of biological chemistry.

[383]  M A Goldberg,et al.  The regulated expression of erythropoietin by two human hepatoma cell lines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[384]  T. McDonald.  Regulation of Megakaryocytopoiesis by Thrombopoietin a , 1987, Annals of the New York Academy of Sciences.

[385]  A. Besarab,et al.  Dynamics of erythropoiesis following renal transplantation. , 1987, Kidney international.

[386]  H. P. Davis.  Pathology Prize Evening Polycythaemia following Renal Transplantation , 1987, Journal of the Royal Society of Medicine.

[387]  A. Flake,et al.  Erythropoietin production by the fetal liver in an adult environment. , 1987, Blood.

[388]  J. Caro,et al.  Physiologic regulation and tissue localization of renal erythropoietin messenger RNA. , 1987, Blood.

[389]  T. McDonald,et al.  High doses of recombinant erythropoietin stimulate platelet production in mice. , 1987, Experimental hematology.

[390]  J. Garcia,et al.  Erythropoietin-hematocrit feedback circuit in the anemia of end-stage renal disease. , 1987, Kidney international.

[391]  J. Caro,et al.  Erythropoietin titers in anemic, nonuremic patients. , 1987, The Journal of laboratory and clinical medicine.

[392]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[393]  C. Winearls,et al.  EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS , 1986, The Lancet.

[394]  K. Aoki,et al.  Characterization and biological effects of recombinant human erythropoietin. , 1986, Immunobiology.

[395]  C. H. Lin,et al.  Chromosomal assignment of the human erythropoietin gene and its DNA polymorphism. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[396]  S. Lewis,et al.  Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. , 1986, The New England journal of medicine.

[397]  E. Goldwasser,et al.  Expression of the erythropoietin gene. , 1986, Blood cells.

[398]  M. Koury,et al.  Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. , 1986, Molecular and cellular biology.

[399]  J. Adamson,et al.  Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity. , 1986, Kidney international.

[400]  C. Shoemaker,et al.  Murine erythropoietin gene: cloning, expression, and human gene homology , 1986, Molecular and cellular biology.

[401]  G. Matzke,et al.  Erythropoietin kinetics in rats: generation and clearance. , 1986, Blood.

[402]  A. Grimes,et al.  Correction of anaemia following renal transplantation: serial changes in serum immunoreactive erythropoietin, absolute reticulocyte count and red‐cell creatine levels , 1985, British journal of haematology.

[403]  C. H. Lin,et al.  Cloning and expression of the human erythropoietin gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[404]  W. Kriz,et al.  Morphologic and functional evidence for oxygen deficiency in the isolated perfused rat kidney. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[405]  J. Adamson,et al.  Anemia of end-stage renal disease (ESRD). , 1985, Kidney international.

[406]  J. Adamson,et al.  Erythropoietin kinetics in normal and uremic sheep. , 1985, The Journal of laboratory and clinical medicine.

[407]  J. Caro,et al.  Uremic inhibitors of erythropoiesis. , 1985, Seminars in nephrology.

[408]  E. Goldwasser,et al.  The role of carbohydrate in erythropoietin action. , 1985, Endocrinology.

[409]  R. Clouse,et al.  Upper gastrointestinal bleeding in patients with chronic renal failure. , 1985, Annals of internal medicine.

[410]  W. Jelkmann,et al.  Erythropoietin production in normoxic and hypoxic rats with increased blood O2 affinity. , 1985, Respiration physiology.

[411]  J. Mcmahon,et al.  Erythropoietin secretion by isolated rat Kupffer cells. , 1984, Experimental hematology.

[412]  J. Caro,et al.  Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions. , 1984, The Journal of laboratory and clinical medicine.

[413]  T. Hawkins,et al.  IS ANAEMIA DURING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS REALLY BETTER THAN DURING HAEMODIALYSIS? , 1983, The Lancet.

[414]  H. Asaba,et al.  Assessment of hemolysis in regular hemodialysis patients by measuring carbon monoxide production rate. , 1983, Clinical nephrology.

[415]  T. McDonald,et al.  Nephrectomy Abolishes the Increase in Small Acetylcholinesterase-Positive Immature Rat Megakaryocytes Induced by Acute Thrombocytopenia 1 , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[416]  F. Thévenod,et al.  Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. , 1983, Kidney international.

[417]  J. Savory,et al.  ALUMINIUM POISONING: DIALYSIS ENCEPHALOPATHY, OSTEOMALACIA, AND ANAEMIA , 1983, The Lancet.

[418]  B. Lacour,et al.  Aluminium-induced, reversible microcytic anemia in chronic renal failure: clinical and experimental studies. , 1983, Clinical nephrology.

[419]  N. Lameire,et al.  Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease. , 1983, Kidney international.

[420]  T. McDonald,et al.  Effects of thrombopoietin on the number and diameter of marrow megakaryocytes of mice. , 1983, Experimental hematology.

[421]  Marilyn E. Miller,et al.  Plasma levels of immunoreactive erythropoietin after acute blood loss in man , 1982, British journal of haematology.

[422]  J. Fisher,et al.  A radioimmunoassay for erythropoietin: serum levels in normal human subjects and patients with hemopoietic disorders. , 1982, The Journal of laboratory and clinical medicine.

[423]  J. Kark,et al.  Erythrocytosis in patients on long-term hemodialysis. , 1982, Annals of internal medicine.

[424]  P. Cotes,et al.  RAPID COMMUNICATION: DIURNAL VARIATION OF SERUM IMMUNOREACTIVE ERYTHROPOIETIN IN A NORMAL SUBJECT , 1982 .

[425]  W. Jelkmann.  Temporal pattern of erythropoietin titers in kidney tissue during hypoxic hypoxia , 1982, Pflügers Archiv.

[426]  P. Cotes.  I. EVIDENCE FOR THE VALIDITY OF THE ASSAY METHOD AND THE PHYSIOLOGICAL RELEVANCE OF ESTIMATES , 1982, British journal of haematology.

[427]  Cotes Pm.  Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. , 1982 .

[428]  W. Jelkmann,et al.  Demonstration of high levels of erythropoietin in rat kidneys following hypoxic hypoxia , 1981, Pflügers Archiv.

[429]  J. Winchester,et al.  Hemosiderosis in hemodialysis patients. , 1981, JAMA.

[430]  J. Fisher,et al.  Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. , 1981, The Journal of clinical investigation.

[431]  E. Cronkite,et al.  Regulatory mechanism of erythropoietin production: effects of hypoxemia and hypercarbia. , 1981, Experimental hematology.

[432]  E. Zanjani,et al.  Studies on the liver to kidney switch of erythropoietin production. , 1981, The Journal of clinical investigation.

[433]  Wallner Sf,et al.  Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure. , 1981 .

[434]  B. Bacon,et al.  Renal artery stenosis with erythrocytosis after renal transplantation. , 1980, Archives of internal medicine.

[435]  G. Barbour.  Effect of parathyroidectomy on anemia in chronic renal failure. , 1979, Archives of internal medicine.

[436]  S. Ebbe.  Experimental and clinical megakaryocytopoiesis. , 1979, Clinics in haematology.

[437]  F. Dagher,et al.  ARE THE NATIVE KIDNEYS RESPONSIBLE FOR ERYTHROCYTOSIS IN RENAL ALLORECIPIENTS? , 1979, Transplantation.

[438]  J. Caro,et al.  Erythropoietin levels in uremic nephric and anephric patients. , 1979, The Journal of laboratory and clinical medicine.

[439]  M. Sohtell,et al.  CO2 along the proximal tubules in the rat kidney. , 1979, Acta physiologica Scandinavica.

[440]  P. Jungers,et al.  Anemia and secondary hyperparathyroidism. , 1978, Archives of internal medicine.

[441]  M. Szmitkowski,et al.  Distribution of CSF (colony stimulating factor) in kidney of the mouse , 1978, Experientia.

[442]  E. Mirand,et al.  Carbon dioxide effects on erythropoietin and erythropoiesis. , 1978, The Journal of laboratory and clinical medicine.

[443]  B. Pollara,et al.  Localization of an adenosine deaminase-binding protein in human kidney. , 1978, The Journal of laboratory and clinical medicine.

[444]  E. Goldwasser,et al.  Extraction of erythropoietin from normal kidneys. , 1978, Endocrinology.

[445]  S. Wallner,et al.  The effect of serum from patients with chronic renal failure on erythroid colony growth in vitro. , 1978, The Journal of laboratory and clinical medicine.

[446]  J. Schooley,et al.  Inhibition of erythropoietin production in unanesthetized rabbits exposed to an acute hypoxic-hypercapnic environment. , 1978, Blood.

[447]  C. Peschle,et al.  Role of the hypophysis in erythropoietin production during hypoxia. , 1978, Blood.

[448]  J. Cook,et al.  Iron balance in hemodialysis patients. , 1977, Annals of internal medicine.

[449]  E. Mirand,et al.  Identification of erythropoietin producing cells in fetal mouse liver cultures. , 1977, Experimental hematology.

[450]  E. Goldwasser,et al.  Purification of human erythropoietin. , 1977, The Journal of biological chemistry.

[451]  J. Bergström,et al.  Hypersequestration of 51Cr-labelled erythrocytes as a criterion for splenectomy in regular hemodialysis patients. , 1977, Clinical nephrology.

[452]  G. Beynon.  The influence of the autonomic nervous system in the control of erythropoietin secretion in the hypoxic rat. , 1977, The Journal of physiology.

[453]  J. Levin,et al.  Relationships between thrombopoiesis and erythropoiesis: with studies of the effects of preparations of thrombopoietin and erythropoietin , 1976 .

[454]  R. E. Smith,et al.  Primary hyperparathyroidism and anemia. , 1976, Archives of internal medicine.

[455]  G. Pampiglione,et al.  INFANTILE SPASMS AND SUBSEQUENT APPEARANCE OF TUBEROUS SCLEROSIS SYNDROME , 1975, The Lancet.

[456]  Penington Dg,et al.  The effect of massive liver resection on platelet kinetics in the rat. , 1975 .

[457]  Y. Yawata,et al.  Abnormal red cell metabolism in patients with chronic uremia: Nature of the defect and its persistence despite adequate hemodialysis. , 1975, Blood.

[458]  E. Goldwasser,et al.  On the mechanism of erythropoietin-induced differentiation. 13. The role of sialic acid in erythropoietin action. , 1974, The Journal of biological chemistry.

[459]  J. Schooley,et al.  Extrarenal Erythropoietin Production by the Liver in the Weanling Rat 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[460]  O. Jonasson,et al.  The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses. , 1973, Annals of internal medicine.

[461]  P. Hochstein,et al.  Erythrocyte deformability in uremic hemodialyzed patients. , 1973, Annals of internal medicine.

[462]  J. A. Harris,et al.  Erythropoietin production in dogs exposed to high altitude and carbon monoxide. , 1973, The American journal of physiology.

[463]  J. Koplan,et al.  Erythropoietin-producing renal cyst and polycythemia vera. Clarification of their relationship. , 1973, The American journal of medicine.

[464]  K. Møllgård,et al.  Evidence against erythropoietin production by the carotid body. , 1973, Respiration physiology.

[465]  W. Fried.  The liver as a source of extrarenal erythropoietin production. , 1972, Blood.

[466]  J. Fisher,et al.  Plasma Disappearance of 125I-Labeled Erythropoietin in Anesthetized Rabbits 1 , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[467]  R. H. Painter,et al.  Studies on the role of sialic acid in the physical and biological properties of erythropoietin. , 1972, Canadian journal of biochemistry.

[468]  E. Nečas,et al.  Unresponsiveness of erythropoietin-producing cells to cyanide. , 1972, American Journal of Physiology.

[469]  C. Peschle,et al.  Mechanism of thyroxine action on erythropoiesis. , 1971, Endocrinology.

[470]  E. Nečas,et al.  Feedback regulation by red cell mass of the sensitivity of the erythropoietin-producing organ to hypoxia. , 1970, Blood.

[471]  J. Adamson,et al.  Disorders of red blood cell production in uremia. , 1970, Archives of internal medicine.

[472]  M. Gross,et al.  On the mechanism of erythropoietin-induced differentiation. VII. The relationship between stimulated deoxyribonucleic acid synthesis and ribonucleic acid synthesis. , 1970, The Journal of biological chemistry.

[473]  R. Alexanian,et al.  Erythropoietin and erythropoiesis in anemic man following androgens. , 1969, Blood.

[474]  D. Howard,et al.  Regulation of erythropoiesis. XXII. Erythropoietin production in the newborn animal. , 1968, Blood.

[475]  J. Fisher,et al.  Erythropoietin production in nephrectomized and hypophysectomized animals. , 1968, The American journal of physiology.

[476]  J W Fisher,et al.  Relationship Between Renal Blood Flow and Erythropoietin Production In Dogs.∗ , 1967, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[477]  D. Penington,et al.  Regulation of Platelet Production: ‘Hypersplenism’ in the Experimental Animal , 1967, British journal of haematology.

[478]  J. Adamson,et al.  Erythropoiesis in patients with renal failure undergoing chronic dialysis. , 1967, The New England journal of medicine.

[479]  C. Reynafarje,et al.  Humoral Control of Erythropoietic Activity in Man During and After Altitude Exposure.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[480]  J. Krog,et al.  Renal Oxygen Tension , 1960, Nature.

[481]  H. Borsook,et al.  Inactivation of Erythropoietin by Neuraminidase and by Mild Substitution Reactions , 1960, Nature.

[482]  E. Goldwasser,et al.  Role of the Kidney in Erythropoiesis , 1957, Nature.

[483]  R. Blattner.  Physiologic control of red cell production , 1956 .

[484]  A. Erslev,et al.  Humoral regulation of red cell production. , 1953, Blood.

[485]  K. Reissmann.  Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. , 1950, Blood.

[486]  E. Bonsdorff,et al.  A Humoral Mechanism in Anoxic Erythrocytosis , 1948 .

[487]  D. Barber,et al.  Cytokine Receptor Signaling , 2010 .

[488]  D. Chae,et al.  Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[489]  J. Prchal,et al.  The HIF2A gene in familial erythrocytosis. , 2008, The New England journal of medicine.

[490]  M. Charbonneau,et al.  Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. , 2006, The Journal of biological chemistry.

[491]  R. Gatti,et al.  Congenital polycythemia with homozygous and heterozygous mutations of von Hippel-Lindau gene: five new Caucasian patients. , 2005, Haematologica.

[492]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[493]  K. Eckardt,et al.  Regulation of erythropoietin production. , 2005, European journal of clinical investigation.

[494]  D. Fabbro,et al.  Hypoxia-induced accumulation of erythropoietin mRNA in isolated hepatocytes is inhibited by protein kinase C , 2004, Pflügers Archiv.

[495]  M. Gassmann,et al.  Non-erythroid functions of erythropoietin. , 2003, Advances in experimental medicine and biology.

[496]  S. Bhattacharya,et al.  Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. , 1999, Genes & development.

[497]  Yan Li,et al.  Erythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System , 1998, Pediatric Research.

[498]  D. Williams,et al.  Signaling through the interaction of membrane-restricted stem cell factor and c-kit receptor tyrosine kinase: genetic evidence for a differential role in erythropoiesis. , 1998, Blood.

[499]  L. Wartman,et al.  Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. , 1998, Gene expression.

[500]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[501]  B. Chong,et al.  Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. , 1997, Blood.

[502]  S. McKnight,et al.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.

[503]  D Grillot,et al.  Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. , 1996, Blood.

[504]  W. Szewczyk,et al.  Erythropoietin concentration in cyst fluid in patients with simple renal cysts. , 1994, Nephron.

[505]  K. Mizuno,et al.  Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue. , 1994, Life sciences.

[506]  D. K. Ganguly,et al.  Involvement of gamma-aminobutyric acid in the stimulatory effect of metoclopramide on gastrointestinal motility. , 1994, Life sciences.

[507]  P. Ratcliffe,et al.  Increased plasma viscosity as a reason for inappropriate erythropoietin formation. , 1993, The Journal of clinical investigation.

[508]  G. Longmore.  Erythropoietin receptor mutations and Olympic glory , 1993, Nature Genetics.

[509]  C. Pérez-Carral,et al.  Anaphylactic reaction to recombinant human erythropoietin. , 1993, Nephron.

[510]  H. Rodemann,et al.  Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. , 1993, Experimental nephrology.

[511]  J. Fandrey,et al.  In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. , 1993, Blood.

[512]  W. Jelkmann,et al.  Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. , 1992, Life sciences.

[513]  C. Bernis,et al.  Erythrocytosis after renal transplantation. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[514]  N. Muirhead,et al.  The role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[515]  P. Lisi,et al.  Separation of carbohydrate-mediated microheterogeneity of recombinant human erythropoietin by free solution capillary electrophoresis. Effects of pH, buffer type and organic additives. , 1991, Journal of chromatography.

[516]  W. Jelkmann,et al.  Modulation of the production of erythropoietin by cytokines: in vitro studies and their clinical implications. , 1990, Contributions to nephrology.

[517]  G. Nyberg,et al.  Erythrocytosis after renal transplantation; treatment by removal of the native kidneys. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[518]  K. Eckardt,et al.  Single-dose pharmacokinetics of recombinant human erythropoietin in patients with various degrees of renal failure. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[519]  M. Le Hir,et al.  Site of erythropoietin formation. , 1989, Contributions to nephrology.

[520]  M. Berridge,et al.  Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. , 1989, Experimental hematology.

[521]  R. Weinmann,et al.  Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure. , 1989, Blood.

[522]  A. Bidani,et al.  Kinetics of CO2 exchange in the kidney. , 1988, Annual review of physiology.

[523]  J. Fisher,et al.  A1 and A2 adenosine receptor regulation of erythropoietin production. , 1988, Life sciences.

[524]  M. Koury,et al.  Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane. , 1987, Blood cells.

[525]  J. Adamson,et al.  Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis. , 1987, Kidney international.

[526]  J. Garcia,et al.  Immunoreactive erythropoietin studies in hypoxic rats and the role of the salivary glands. , 1987, Experimental hematology.

[527]  R. Eddy,et al.  Regional assignment of the erythropoietin gene to human chromosome region 7pter----q22. , 1986, Cytogenetics and cell genetics.

[528]  M. Miller,et al.  Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. , 1985, Nephron.

[529]  E. Fritsch,et al.  Isolation and characterization of genomic and cDNA clones of human erythropoietin , 1985, Nature.

[530]  M. Brezis,et al.  Selective vulnerability of the medullary thick ascending limb to anoxia in the isolated perfused rat kidney. , 1984, The Journal of clinical investigation.

[531]  J. Caro,et al.  Pure erythrocytosis classified according to erythropoietin titers. , 1984, The American journal of medicine.

[532]  S. Hopfer,et al.  Erythropoietin-mediated erythrocytosis in rodents after intrarenal injection of nickel subsulfide. , 1982, The Yale journal of biology and medicine.

[533]  W. Fried,et al.  Detection of high erythropoietin titers in renal extracts of hypoxic rats. , 1981, The Journal of laboratory and clinical medicine.

[534]  J. Fisher.  Mechanism of the anemia of chronic renal failure. , 1980, Nephron.

[535]  W. Clark,et al.  Correctable factors contributing to the anemia of dialysis patients. , 1977, Nephron.

[536]  E. Sabbaga,et al.  Polycythemia after Kidney Transplantation , 1977 .

[537]  E. Nečas,et al.  Species specificity of guinea pig erythropoietin. , 1976, Endocrinologia experimentalis.

[538]  Mcdonald Tp.  Role of the kidneys in thrombopoietin production. , 1976 .

[539]  G. Barlow,et al.  Thrombopoietin production by human embryonic kidney cells in culture. , 1975, The Journal of laboratory and clinical medicine.

[540]  T. Berne,et al.  Hypersplenism in the Uremic Hemodialyzed Patient , 1972 .

[541]  P. Abbrecht,et al.  Plasma erythropoietin in men and mice during acclimatization to different altitudes. , 1972, Journal of applied physiology.

[542]  S. Halvorsen.  Effects of growth hormone on erythropoiesis in the intact rabbit and the polycythemic mouse. , 1966, Acta physiologica Scandinavica.

[543]  T. J. Mcmanus,et al.  AN ION TRANSPORT DEFECT IN ERYTHROCYTES FROM UREMIC PATIENTS. , 1964, Transactions of the Association of American Physicians.

[544]  F. Stohlman.  REGULATION OF ERYTHROPOIESIS , 1962 .

[545]  E. Goldwasser,et al.  Studies on erythropoiesis. V. The effect of cobalt on the production of erythropoietin. , 1958, Blood.

[546]  E. Bonsdorff.  On the presence of erythropoietins in the plasma from sheep foetuses during the latter half of gestation. , 1949, Acta physiologica Scandinavica.